|
Volumn 16, Issue 2, 2002, Pages 91-97
|
Effects of lithium carbonate on hematopoietic cells in patients with persistent neutropenia following chemotherapy or radiotherapy
|
Author keywords
Cancer therapy; Cost effectiveness; Cytokines; Leucocytopenia; Lithium; Neutropenia
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYTOSTATIC AGENT;
HEMOPOIETIC GROWTH FACTOR;
LEUKOMINERASE;
LITHIUM CARBONATE;
RECOMBINANT COLONY STIMULATING FACTOR;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CELL COUNT;
CELL PROLIFERATION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
DISEASE SEVERITY;
DRUG EFFECT;
DRUG INDICATION;
DRUG MECHANISM;
DRUG RESPONSE;
DRUG SAFETY;
DRUG TOLERABILITY;
EOSINOPHIL;
HEADACHE;
HEALTH CARE COST;
HEMATOPOIETIC CELL;
HUMAN;
LEUKOPENIA;
LYMPHOCYTE COUNT;
MAJOR CLINICAL STUDY;
MUSCLE WEAKNESS;
NEUTROPENIA;
POLYDIPSIA;
POLYURIA;
PRIORITY JOURNAL;
RADIATION SICKNESS;
RANDOMIZED CONTROLLED TRIAL;
TREMOR;
TUMOR IMMUNOLOGY;
VERTIGO;
|
EID: 0036329267
PISSN: 0946672X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0946-672X(02)80034-7 Document Type: Article |
Times cited : (16)
|
References (44)
|